Neuro-cognitive and psychosocial intervention for people with epilepsy

Testing the Efficacy of a Neuro-cognitive and Psychosocial Intervention Module in People With Epilepsy

Not applicable Interventional Post Graduate Institute of Medical Education and Research, Chandigarh · NCT06537986

This study is testing a new program designed to help people with drug-resistant epilepsy improve their quality of life by focusing on their thinking skills and emotional well-being.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment60 (estimated)
Ages18 Years to 45 Years
SexAll
SponsorPost Graduate Institute of Medical Education and Research, Chandigarh Academic / other
Locations1 site (Chandigarh)
Trial IDNCT06537986 on ClinicalTrials.gov

What this trial studies

This study aims to develop and test a specialized Neuro-cognitive and psychosocial intervention module for patients with drug-resistant epilepsy (DRE). It will assess the efficacy of this module in improving the quality of life for DRE patients by addressing cognitive and psychosocial issues. The study will involve a randomized control trial design, where participants will be assigned to either an intervention group receiving the module or a control group receiving standard follow-up. Comprehensive pre and post-assessments will be conducted to evaluate outcomes.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals aged 18 to 45 with drug-resistant epilepsy who are willing to participate.

Not a fit: Patients with other neurological disorders, major psychiatric conditions, or those who cannot provide informed consent may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance the quality of life for patients suffering from drug-resistant epilepsy.

How similar studies have performed: While there is limited evidence in the Indian context, similar cognitive-behavioral interventions have shown promise in other populations, indicating potential for success.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants of 18 - 45 years of age.
2. either gender
3. Willing to participate and sign the informed consent

Exclusion Criteria:

1. Patients with other neurological disorders
2. any other trial at inclusion
3. should not have any major psychiatric disorder
4. pregnant and lactating mothers
5. also, patients who would not be giving informed consent
6. Patients with intellectual disabilities.

Where this trial is running

Chandigarh

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Drug Resistant EpilepsyEpilepsy,NeurocognitivePsychosocialmodule
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.